Today: 12 April 2026
Browse Category

NASDAQ:EVOK 4 November 2025

Evoke Pharma (EVOK) Stock Skyrockets on Buyout News – What’s Behind the Surge?

Evoke Pharma (EVOK) Stock Skyrockets on Buyout News – What’s Behind the Surge?

Evoke Pharma shares jumped about 135% to $10.77 on Nov. 4, 2025, after announcing a buyout by QOL Medical for $11 per share in cash. The $17 million deal, approved by both boards, is expected to close by year-end. Evoke’s only product is Gimoti, an FDA-approved nasal spray for diabetic gastroparesis. Q2 net sales rose 47% to $3.8 million, but the company remains unprofitable.

Stock Market Today

  • Investors Increase Short Bets on Greggs Shares Amid Growth Concerns
    April 12, 2026, 4:08 AM EDT. Greggs (LSE:GRG) shares have tumbled, sparking heavy short interest at 13.8%, equivalent to about £219 million wagered against the stock, according to Research Tree. The FTSE 250 bakery chain faces growth challenges as it nears UK market saturation, limiting new store openings and relying on weak like-for-like sales amid subdued consumer spending. Rising energy and staff costs are pressuring profit margins, contributing to the share price decline. Despite these headwinds, Greggs' solid customer value proposition and cost efficiency maintain long-term appeal. However, its current price-to-earnings (P/E) ratio of 13.5 reflects caution, leaving room for further downside if earnings fail to improve. Investors are weighing these factors amid volatile market sentiment and potential short-squeeze scenarios.

Latest article

Wall Street Feels the Heat (and Thrill): Fed Cuts, Tariffs & Mega-Mergers Set NYSE Buzz

US Stock Market Today: Live Updates 12.04.2026

12 April 2026
Futu Holdings (FUTU) rose 10.2% in the past week but trades 13.4% below its January level. Shares closed at $154.50, while analysts estimate intrinsic value at $245.48. The company posted a 92.2% return over 12 months. Valuation models indicate earnings exceed risk costs, supporting long-term growth projections.
India F-35 Deal Hits Pause: Lockheed Martin Says No Direct Talks, U.S. Door Still Open

India F-35 Deal Hits Pause: Lockheed Martin Says No Direct Talks, U.S. Door Still Open

11 April 2026
Lockheed Martin said it is not in direct talks with India over the F-35, clarifying that any approach must go through official U.S. and Indian channels under the Foreign Military Sales process. Indian officials confirmed no formal discussions on acquiring the F-35 have begun. India recently approved a $40 billion military upgrade, including other fighter jets, while Lockheed’s F-21 remains in a separate competition.
Why SNOW Stock Is Falling Again: Snowflake Nears 52-Week Low as AI Worries Hit Software

Why SNOW Stock Is Falling Again: Snowflake Nears 52-Week Low as AI Worries Hit Software

11 April 2026
Snowflake shares fell 8.4% to $121.11 on Friday after an 11.7% drop Thursday, as investors sold off software stocks amid concerns over new AI tools from Anthropic and OpenAI. The stock now trades just above its 52-week low. The S&P 500 Software and Services Index is down 25.5% for the year. Snowflake reported fourth-quarter product revenue of $1.23 billion, up 30% from a year earlier.
Wall Street Feels the Heat (and Thrill): Fed Cuts, Tariffs & Mega-Mergers Set NYSE Buzz

US Stock Market Today: Live Updates 11.04.2026

11 April 2026
LIVEMarkets rolling coverageStarted: April 11, 2026, 12:00 AM EDTUpdated: April 11, 2026, 11:59 PM EDT DocuSign Stock Review: Is the 42% Yearly Drop a Buying Opportunity? April 11, 2026, 11:59 PM EDT. DocuSign (DOCU) shares have fallen 42.3% over the past year, raising questions about their value. Despite recent weakness, a Discounted Cash Flow (DCF) analysis suggests the stock is **68.1% undervalued**, with estimated intrinsic value around $134.42 versus a current price near $42.89. The DCF model projects growing free cash flows from $990 million in 2026 to $1.37 billion by 2029. Investors remain cautious amid evolving software spending trends
Go toTop